http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#Head http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#provenance http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#pubinfo http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion http://purl.obolibrary.org/obo/DOID_7148 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_7148 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00482 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association http://www.w3.org/2000/01/rdf-schema#label carefully consider the potential benefits and risks of celebrex and other treatment options before deciding to use celebrex use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings and precautions 5 celebrex is a nonsteroidal anti inflammatory drug indicated for osteoarthritis oa 1 1 rheumatoid arthritis ra 1 2 juvenile rheumatoid arthritis jra in patients 2 years and older 1 3 ankylosing spondylitis as 1 4 acute pain ap 1 5 primary dysmenorrhea pd 1 6 familial adenomatous polyposis fap adjunct to usual care 1 7 celebrex is indicated for relief of the signs and symptoms of oa see clinical studies 14 1 celebrex is indicated for relief of the signs and symptoms of ra see clinical studies 14 2 celebrex is indicated for relief of the signs and symptoms of jra in patients 2 years and older see clinical studies 14 3 celebrex is indicated for the relief of signs and symptoms of as see clinical studies 14 4 celebrex is indicated for the management of ap in adults see clinical studies 14 5 celebrex is indicated for the treatment of pd see clinical studies 14 5 celebrex is indicated to reduce the number of adenomatous colorectal polyps in fap as an adjunct to usual care e g endoscopic surveillance surgery it is not known whether there is a clinical benefit from a reduction in the number of colorectal polyps in fap patients it is also not known whether the effects of celebrex treatment will persist after celebrex is discontinued the efficacy and safety of celebrex treatment in patients with fap beyond six months have not been studied see warnings and precautions 5 15 clinical studies 14 6 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/SymptomaticReliefIndication https://identifiers.org/drugbank:DB00482 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#provenance http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#pubinfo http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig http://purl.org/nanopub/x/hasSignature Q+JKR+KWu+q1TZJIbH4wJBB0eB57khi3w4xbAZ7BNwbgTROfp1FtUe4c3c8lJ4DuDVPF+2tBkm7EDbYn3MdVk77ymK9I32iHIFf8xgSNrNOIkkljujXDjdrFA0dqDMkYUSK0GF80q/YD/QK6Klm4l4VU32WA12wAGWsGjxITkxk= http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://purl.org/dc/terms/created 2021-06-29T08:54:30.583+02:00 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAm5e2akNdHYpxzb0kWP5wMGafKOU9-YrxdlcY7bw8T7Q https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs